National Institute of Allergy and Infectious Diseases
  National Institutes of Health
NIAID Home Health & Science Research Funding Research News & Events Labs at NIAID About NIAID

About NIAID
 Overview
 Organization
  Organizational Charts
  Office of the Director
  DAIDS
   CIPRA
  DAIT
  DCR
  DEA
  DIR
  DMID
  VRC
 Director's Page
 Working at NIAID
 Finding People
 Visitor Information


Division of Acquired Immunodeficiency Syndrome (DAIDS)

Epidemiological/Long-Term Cohort Studies

Comprehensive International Program for Research on AIDS (CIPRA)

The goals of CIPRA are to provide long-term support to developing countries to (1) plan and implement a comprehensive HIV/AIDS prevention and treatment research agenda relevant to their populations; and (2) enhance the infrastructure necessary to conduct such research. The program provides flexibility for applicants with different levels of research capabilities.

International Epidemiologic Databases to Evaluate AIDS (IeDEA)

A data analysis center that compiles data from DAIDS-funded international research use by DAIDS-funded investigators to answer population level questions on HIV variants and resistance, HIV pathogenesis in different settings, success of HAART therapy, treated history of HIV in different populations, success of prevention strategies, or vaccine related questions. The center also fosters collaborations with other large databases.

Multicenter AIDS Cohort Study (MACS)

An ongoing prospective study of the natural and treated histories of HIV-1 infection in 6,973 homosexual and bisexual men at sites located in Baltimore, Chicago, Pittsburgh and Los Angeles.

Pediatric HIV/AIDS Cohort Study (PHACS)

A multi-institute initiative (Eunice Kennedy Shriver National Institute of Child Health and Human Development [NICHD] and NIAID) investigating the long-term safety of fetal/infant exposure to antiretroviral drugs, as well as the effects of perinatally acquired HIV infection on adolescent development.

Women’s HIV Interdisciplinary Network (WHIN)

A research program focusing on HIV pathogenesis in women, including gender differences in immunology, pharmacology, response to therapy, complications of therapy, and immunological, virological, genetic, and behavioral aspects of transmission.

Women’s Interagency HIV Study (WIHS)

A cohort study established in 1993 and currently following 2,404 HIV-infected and uninfected women to examine the natural history of HIV among women in an era of combination treatments referred to as highly active antiretroviral therapy (HAART).

back to top


Highlights

Dr. Carl Dieffenbach Appointed Director of the NIAID Division of AIDS
Feb. 1, 2008

News Releases

National Latino AIDS Awareness Day—October 15, 2008 | En Español
Oct. 8, 2008

NIAID Media Availability: New Findings Indicate HIV/AIDS Pandemic Began around 1900, Earlier than Previously Thought
Oct. 1, 2008

Study Reveals Link between Apobec3 Gene and Neutralizing Antibody Response to Retrovirus
Sept. 4, 2008

NIAID Media Availability: NIAID to Fund Broad Range of Basic HIV Vaccine Discovery Research
Aug. 29, 2008

Special Announcements

Status of NIAID Adenovirus-based Vaccine Studies

Considerations for HIV Vaccine Clinical Trials in Adolescents

Guidance regarding HIV anti-retroviral treatment in developing countries

Search in About NIAID
 
E-mail Icon E-mail this page
Print Icon Print this page
Plug-ins and Viewers
To open PDFs on this page, download and install the Adobe Acrobat Reader.

Highlights

Dr. Carl Dieffenbach Appointed Director of the NIAID Division of AIDS
Feb. 1, 2008

News Releases

National Latino AIDS Awareness Day—October 15, 2008 | En Español
Oct. 8, 2008

NIAID Media Availability: New Findings Indicate HIV/AIDS Pandemic Began around 1900, Earlier than Previously Thought
Oct. 1, 2008

Study Reveals Link between Apobec3 Gene and Neutralizing Antibody Response to Retrovirus
Sept. 4, 2008

NIAID Media Availability: NIAID to Fund Broad Range of Basic HIV Vaccine Discovery Research
Aug. 29, 2008

Special Announcements

Status of NIAID Adenovirus-based Vaccine Studies

Considerations for HIV Vaccine Clinical Trials in Adolescents

Guidance regarding HIV anti-retroviral treatment in developing countries